Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on September 25, 2026

Sep. 25, 2026

Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion

Indeterminate GlobeNewswire

Sep. 25, 2026

C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting

Indeterminate GlobeNewswire

Sep. 25, 2026

Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference

Indeterminate GlobeNewswire

Sep. 25, 2026

Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN

Indeterminate GlobeNewswire

Sep. 25, 2026

Omotesando Helene Clinic and Maison Privé Clinic Sign Cooperation Agreement on International Medical Exchange and Patient Support

Indeterminate GlobeNewswire

Sep. 25, 2026

Federal Life Appoints Carlos Paiva Chief Legal Officer, General Counsel & Corporate Secretary

Indeterminate GlobeNewswire

Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Indeterminate GlobeNewswire

Sep. 25, 2026

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 25, 2026

Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior

Indeterminate GlobeNewswire